Holen Sie sich die Stockscreener-App
1.25
2.34%
-0.03
Schlusskurs vom Vortag:
$1.28
Offen:
$1.29
24-Stunden-Volumen:
39,414
Relative Volume:
0.60
Marktkapitalisierung:
$20.84M
Einnahmen:
$3.20M
Nettoeinkommen (Verlust:
$-10.90M
KGV:
-1.8551
EPS:
-0.6738
Netto-Cashflow:
$-7.92M
1W Leistung:
+0.00%
1M Leistung:
+11.61%
6M Leistung:
-14.97%
1J Leistung:
+46.89%
1-Tages-Spanne:
$1.22
$1.29
1-Wochen-Bereich:
$1.18
$1.39
52-Wochen-Spanne:
$0.83
$2.46
Marker Therapeutics Inc Stock (MRKR) Company Profile
Firmenname
Marker Therapeutics Inc
Sektor
Branche
Telefon
(713) 400-6400
Adresse
2450 HOLCOMBE BLVD, HOUSTON, TX
Compare MRKR vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRKR
Marker Therapeutics Inc
|
1.25 | 21.34M | 3.20M | -10.90M | -7.92M | -0.6738 |
VRTX
Vertex Pharmaceuticals Inc
|
520.92 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.06 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,005.86 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.34 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.45 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-03-25 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-05-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-05-30 | Eingeleitet | ROTH Capital | Buy |
| 2019-03-01 | Eingeleitet | Janney | Buy |
| 2018-12-03 | Hochstufung | Piper Jaffray | Neutral → Overweight |
Alle ansehen
Marker Therapeutics Inc Aktie (MRKR) Neueste Nachrichten
Marker Therapeutics (MRKR) Holds at $1.24 as Shares Trade Flat Within RangeVolume Spike Alerts - siam.in
Marker Therapeutics Inc. (MRKR) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Thyroid tablets recalled because they could be ‘superpotent,' lead to hyperthyroidism - nbcchicago.com
Is Marker Therapeutics (NASDAQ:MRKR) In A Good Position To Deliver On Growth Plans? - webull.com
H.C. Wainwright reiterates Marker Therapeutics stock rating at buy By Investing.com - Investing.com India
H.C. Wainwright reiterates Marker Therapeutics stock rating at buy - Investing.com
US High Growth Tech Stocks To Watch In August 2026 - simplywall.st
Marker Therapeutics (MRKR) Rises 1.75%, Holding Above Key $1.10 SupportIchimoku Kumo Twist - vinanet.vn
Marker Therapeutics Stock Price Forecast. Should You Buy MRKR? - StockInvest.us
Marker Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
MRKR Advances 2.7% to $1.14 as Biotech Stock Holds Above Key SupportVanna Flow - Vinanet
Marker Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
CCORF Maintains Marker Therapeutics(MRKR.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Stock List: Research Stocks from Around the World - GuruFocus
Marker Therapeutics Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Marker Therapeutics Inc (MRKR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MRKR Q1 2026 Earnings: Narrower-Than-Expected Loss of $0.16 Per Share Marks 14.44% EPS SurpriseProfit Inflection Point - vinanet.vn
MRKR Q1 2026 Earnings: Narrower Loss Beats Estimates as Investors Focus on Clinical MilestonesGuidance Downgrade Alert - vinanet.vn
Marker Therapeutics, Inc. Revenue Breakdown – NASDAQ:MRKR - TradingView
Marker Therapeutics Inc (MRKR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Marker Therapeutics Inc (MRKR) Balance Sheet - TradingKey
Marker Therapeutics Inc (MRKR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Marker Therapeutics Inc (MRKR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Marker Therapeutics Inc (MRKR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
MRKR|Marker Therapeutics Inc|Price:1.200|Chg%:-0.020 - TradingKey
MRKR|Marker Therapeutics Inc|Price:1.220|Chg%:-0.050 - TradingKey
Marker Therapeutics Inc (MRKR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
US High Growth Tech Stocks to Watch for Potential Expansion - simplywall.st
High Growth Tech Stocks In The US Market - simplywall.st
Exploring High Growth Tech Stocks In The US For July 2026 - simplywall.st
MRKR Q1 2026 Earnings: Narrower Loss Beats Estimates as Pipeline Progress ContinuesGuidance Revision Trend - vinanet.vn
MRKR Q1 2026 Earnings: Narrower Loss Slightly Beats Expectations as Stock SlipsRevenue Warning Signal - vinanet.vn
Marker Therapeutics (MRKR) Slips 4.43% as Biotech Struggles, Holds Above $1.43 SupportBreakout Confirmation - dars.gov.et
Wainwright reiterates Buy on Marker Therapeutics stock, $10 target By Investing.com - Investing.com Canada
Wainwright reiterates Buy on Marker Therapeutics stock, $10 target - Investing.com
MSN Money - MSN
Marker Therapeutics, Inc.'s (NASDAQ:MRKR) Profit Outlook - simplywall.st
MRKR Q1 2026 Earnings: Narrower Loss Surpasses ExpectationsRevenue Growth Outlook - dars.gov.et
US High Growth Tech Stocks to Watch - simplywall.st
Marker Therapeutics Surges 11%: Key Levels and Potential Catalysts in FocusStandard Deviation - dars.gov.et
Exploring 3 High Growth Tech Stocks in the US Market - simplywall.st
Price to earnings forward of Marker Therapeutics, Inc. – NASDAQ:MRKR - TradingView
Marker Therapeutics Inc. (MRKR) Posts Modest Gain as Shares Approach Key ResistanceCash Flow Strong Stocks - dars.gov.et
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker - The Globe and Mail
MRKR Forecast — Price Target — Prediction for 2027 - TradingView
Marker Therapeutics, Inc. Actuals & Estimates (NASDAQ:MRKR) - TradingView
Price to sales forward of Marker Therapeutics, Inc. – NASDAQ:MRKR - TradingView
Price to book forward of Marker Therapeutics, Inc. – NASDAQ:MRKR - TradingView
GX1 Forecast — Price Target — Prediction for 2027 - TradingView
5 Small Drug Stocks to Invest in Amid a Biotech Comeback - Eastern Progress
Finanzdaten der Marker Therapeutics Inc-Aktie (MRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
2.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):